Search clinical trials for: Selective Norepinephrine Reuptake Inhibitor

Total 69218 results

Janssen Research & Development, LLC

Recruiting

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE)

Depressive Disorder, Major

United States, Korea, Republic of, Spain, Argentina, United Kingdom, Sweden, Italy, Germany, France, Canada, Brazil
Göteborg University
Arvid Carlsson Research AB

Recruiting

OSU6162 as add-on in SSRI/SNRI-resistant Depression (ODEN)

Depressive Disorder | Depression | Depressive Disorder, Treatment-Resistant | Depressive Episode | Recurrent Depressive Disorder | Recurrent Depression

Sweden
Adams Clinical

Recruiting

Tracking Response to Antidepressants in Advance of Investigational Trials (TRAIT)

Major Depressive Disorder

United States
University of Washington
Patient-Centered Outcomes Research Institute; Boston University; Washington State... and other collaborators

Active, not recruiting

Sequenced Treatment Effectiveness for Posttraumatic Stress (STEPS)

PTSD

United States
Dr. Nazanin Alavi
Online PsychoTherapy Clinic

Completed

Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions

Generalized Anxiety Disorder

Canada
Janssen Research & Development, LLC

Terminated

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

Depressive Disorder, Major

United States, United Kingdom
Indiana University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Depression | Insulin Resistance | PreDiabetes | Type 2 Diabetes | Depressive Symptoms | Major Depressive Disorder | Dysthymic Disorder

United States
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

Depression | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Stroke | Depressive Symptoms | Major Depressive Disorder | Dysthymic Disorder

United States
Janssen Research & Development, LLC

Completed

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States
Adams Clinical

Completed

Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study (TRAIT-RS)

Major Depressive Disorder

United States
Jazz Pharmaceuticals

Withdrawn

Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

Post-Traumatic Stress Disorder
Hospital Clinic of Barcelona

Completed

Risk Factors for AD-Associated Switch to Mania

Bipolar Disorder

Spain
University of Ottawa
Allergan

Active, not recruiting

Levomilnacipran in Healthy Males

None (i.e. Healthy Volunteers)

Canada
Centre Hospitalier Rouffach
University Hospital, Strasbourg, France

Unknown

Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.

Depressive Disorder | Hormone Disturbance

France
Shanghai Mental Health Center
RenJi Hospital; Huashan Hospital; Shanghai 10th People's Hospital; Shanghai Jiao... and other collaborators

Unknown

Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment Classification

Major Depressive Disorder

China
Shanghai Mental Health Center
Guangzhou Psychiatric Hospital; Shanghai Jiao Tong University School of Medicine and other collaborators

Unknown

A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features

Major Depressive Disorder

China
The Cleveland Clinic

Completed

Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI

Bipolar Disorder | Major Depression

United States
Second Affiliated Hospital, School of Medicine,...

Unknown

MRI Study of Antidepressants in the Treatment of Refractory Functional Dyspepsia

Therapeutic Mechanism of Antidepressants for Refractory FD

China
University of North Texas Health Science Center

Completed

The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment (DEMO)

Depression | Mild Cognitive Impairment

United States
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

Anxiety Disorders

United States
prof. Peter de Jonge

Unknown

Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis

Anxiety Disorders | Generalized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Post-traumatic Stress Disorder | Obsessive-compulsive Disorder
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
Duke University
National Institute of Mental Health (NIMH)

Completed

Antidepressant Safety in Kids Study (ASK)

Obsessive Compulsive Disorder | Anxiety Disorders | Eating Disorders | Depressive Disorders

United States
Duke University

Completed

Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone

Major Depressive Disorder (MDD)

United States
Pamlab, Inc.
Baylor Health Care System; Red Oak Psychiatry Associates, PA

Completed

Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

Major Depressive Disorder

United States
Massachusetts General Hospital
Patient-Centered Outcomes Research Institute

Not yet recruiting

Sequential Multiple Assignment Randomized Trial for Bipolar Depression (SMART-BD)

Depression | Bipolar I Disorder

United States, Canada
University of Oxford

Not yet recruiting

7T Amygdala and Citalopram Study (7TAC)

Depressive Disorder | Depression | Mood Disorders | Cognition | Emotional Processing
Axsome Therapeutics, Inc.

Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol (ENGAGE)

Binge-Eating Disorder

United States
Axsome Therapeutics, Inc.

Recruiting

SUNOSI® (Solriamfetol) Pregnancy Registry

Obstructive Sleep Apnea | Narcolepsy | Pregnant Women and Their Offspring

United States
Stanford University

Not yet recruiting

Stanford and University of Illinois Chicago ACE-D Study (ACE-D)

Depression

United States
University of Bern
Swiss National Science Foundation; University of Zimbabwe

Not yet recruiting

The Friendship Bench Plus Trial (FB+)

Major Depressive Disorder | Severe Depressive Episode Without Psychotic Symptoms

Zimbabwe
Axsome Therapeutics, Inc.

Recruiting

Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol (PARADIGM)

Major Depressive Disorder

United States
Xiao Wang

Recruiting

Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen

Estrogen | Postmenopausal Depression

China
Germans Trias i Pujol Hospital

Not yet recruiting

Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants (LYMPHODEP)

Depression | Inflammation | Immunity | Antidepressants

Spain
Qinghai Red Cross Hospital

Recruiting

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Advanced Cancer | Progression Free Survival | Olanzapine

China
Fudan University

Not yet recruiting

NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens

Chemotherapy-induced Nausea and Vomiting | Highly Emetogenic Chemotherapy
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Schizophrenia, Schizoaffective Disorder

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

Schizophrenia

United States
China Medical University Hospital

Not yet recruiting

Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

Obstructive Sleep Apnea of Adult
Rajavithi Hospital

Not yet recruiting

Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer With Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial

Weight Gain
Brigham and Women's Hospital

Recruiting

Trazodone on OSA Endotypes

Obstructive Sleep Apnea

United States
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

Insomnia | Blood Pressure | Insomnia Chronic | Insomnia, Primary | Blood Pressure, High

United States, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Schizophrenia

China
Centre for Addiction and Mental Health

Recruiting

Effects of Antipsychotics on Brain Insulin Action in Females

Insulin Resistance | Type 2 Diabetes | Menstrual Cycle | Antipsychotics

Canada
Asceneuron S.A.

Recruiting

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

Drug Drug Interaction

Netherlands
Mostafa Bahaa

Recruiting

Paroxetine Safety and Efficacy in Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
Axsome Therapeutics, Inc.

Recruiting

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Major Depressive Disorder

United States
Jonsson Comprehensive Cancer Center

Not yet recruiting

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Colorectal Adenocarcinoma

United States
Xijing Hospital of Digestive Diseases

Recruiting

Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation

Brain Connectivity | Constipation - Functional | fMRI | Treatment Efficacy | Fluoxetine | Somatic Symptom | Refractory Constipation | Mental Symptom

China

Search clinical trials for: Selective Norepinephrine Reuptake Inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations